Germany
,October 23, 2023
Change in BLS Management: Ronan Donohue assumes the role of President for the Global Business Unit Biopharma and Life Sciences
Ronan Donohue, currently in charge of Global Project Delivery and Engineering for the Global Business Unit Biopharma and Life Sciences (GBU BLS), will take over the role of President for the GBU on November 1, 2023. Based in Ireland, Donohue will report to Exyte CEO Dr. Wolfgang Büchele, who oversees the GBU BLS at the board level. Chris Miller has stepped down from his position as President of the Global Business Unit Biopharma and Life Sciences to explore new opportunities outside of Exyte.
Loading….